Clinical trialNo phase (not a drug trial)Unknown
Randomised Trial Evaluating the Benefit of a Fitness Tracker Based Workout During Radiotherapy
Randomisierte Studie Zum Nutzen Eines Fitnesstracker Basierten Aktivitätstrainings während Einer Strahlentherapeutischen Behandlung (OnkoFit II Studie)
- Outcome
- Outcome unknown
- Phase
- No phase (not a drug trial)
- Status
- Unknown
- Study type
- Interventional
- Start
- 1 August 2020
- Listed end
- 1 August 2025
- Enrollment
- 201 participants
- Sites
- 1
- Primary outcomes
- Evaluation of the impact of an Activity tracker based Fitness programme on the Qualitiy of Life after oncological Therapy
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 18 August 2020
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
Evaluation of the impact of an activity tracker based fitness programme on the Qualitiy of Life after oncological therapy.
Detailed description public domain (ClinicalTrials.gov)
This monocentric, three-arm, randomized, controlled clinical trial evaluates the effect of an activity tracker based exercise program in cancer patients on the Quality of life after oncological therapy. Quality of Life and the intensity of fatigue will be documented with the FACT-G total score of the FACIT Questionnaire six months after completion of radiotherapy.